1118
Helvetica Chimica Acta – Vol. 89 (2006)
2. 3,4-Didehydro-b-ionone Isomers. 2.1. 3,4-Didehydro-b-ionone (4; =(3E)-4-(2,6,6-Trimethylcyclo-
hexa-1,3-dien-1-yl)but-3-en-2-one). Epoxidation of racemic a-ionone (1) with 3-chloroperbenzoic acid
[12a] afforded 4,5-epoxy-4,5-dihydro-a-ionone (8a/8b 5 :1; 75%) (NMR analysis). According to [10a],
8a/8b was treated with NaOMe in dry MeOH. The obtained crude 4-hydroxy-b-ionone was then treated
with TsOH [8c] to afford pure 4 (72%; 96% pure by GC, tR 16.7). IR, 1H-NMR, MS: in accordance with
those reported [9b].
2.2. 3,4-Didehydro-7,8-dihydro-b-ionone (=4-(2,6,6-Trimethylcyclohexa-1,3-dien-1-yl)butan-2-one;
5). Bu
[PdCl2(PPh3)2] (140 mg, 0.2 mmol), NH4Cl (500 mg, 9.4 mmol), and H2O (0.2 ml, 11.2 mmol) in THF
(50 ml) under N2. After 3 h, Et2O (150 ml) was added and the soln. was washed with brine (50 ml) and
A
AHCTREUNG
evaporated. The residue was dissolved in AcOEt (80 ml) and stirred with a sat. NaF soln. (25 ml) for
5 h. The precipitate formed was filtered and the filtrate evaporated. The residue was purified by CC (hex-
ane/AcOEt 95 :5) and bulb-to-bulb distillation: pure 5 (700 mg, 86%; 95% pure by GC, tR 15.1). IR, 1H-
NMR, MS: in accordance with those reported [9b].
3. Racemic 3,4-Didehydro-g-ionone Isomers. 3.1. cis/trans-4-Hydroxy-g-ionone (=(3E)-4-(cis/trans-
5-Hydroxy-2,2-dimethyl-6-methylenecyclohexyl)but-3-en-2-one; 10a/10b). At ꢀ788, 10M BuLi in hexane
i
(55 ml) was added dropwise to Pr2NH (58 g, 573 mol) in dry THF (300 ml) under N2. The mixture was
stirred at ꢀ788 for 30 min, then a soln. of 8a/8b (52 g, 0.25 mol) in dry THF (60 ml) was added dropwise.
The mixture was gradually warmed to r.t. (1 h) and then heated under reflux for 3 h (TLC monitoring).
After cooling to r.t., the mixture was poured into a mixture of crushed ice and 5% HCl soln. (850 ml) and
extracted with Et2O (3×200 ml). The org. phase was successively washed with sat. aq. NH4Cl soln. (100
A
ml) and brine, dried (Na2SO4), and evaporated. The residue was purified by CC (hexane/AcOEt 9 :1 !
hexane/AcOEt 1:1): 11 (3.1 g, 6%) followed by 10a/10b (41.5 g, 80%).
Data of 1-(2,2-Dimethyl-8-methylene-6-oxabicyclo[3.2.1]oct-7-yl)propan-2-one (11): 98% pure by
1
GC, tR 15.4. Colorless oil. IR: 1716, 1366, 1159, 1059, 1013, 965, 892. H-NMR: 4.97 (s, 1 HꢀC=C(8));
4.78 (s, 1 HꢀC=C(8)); 4.58 (t, J=6.7, HꢀC(7)); 4.31 (d, J=4.5, HꢀC(5)); 2.69–2.60 (dd, J=16.1, 6.7,
1 H, CH2
G
COMe); 2.14 (s, MeCO); 1.86 (s, HꢀC(1));
1.81–1.73 (m, 1 H), 1.73–1.62 (m, 1 H), 1.60–1.49 (m, 1 H), 1.20 (dd, J=13.5, 5.5, 1 H) (CH2(3)
CH2(4)); 1.03 (s, 1 MeꢀC(2)); 0.94 (s, 1 MeꢀC(2)). 13C-NMR: 206.9; 149.2; 104.2; 77.7; 74.4; 57.8;
49.8; 35.3; 31.7; 31.4; 30.6; 28.3; 26.2. MS: 208 (1, M+), 193 (5), 175 (2), 165 (6), 157 (1), 150 (30), 147
(10), 135 (20), 122 (10), 119 (9), 107 (36), 95 (20), 91 (18), 81 (18), 79 (19), 69 (13), 67 (11), 55 (17), 53
(12), 43 (100). Anal. calc. for C13H20O2: C 74.96, H 9.68; found: C 75.05, H 9.70.
Data of 10a/10b: 96% pure by GC, tR 20.8 (10a) and tR 20.5 (10b), deduced from the mixture. IR:
1
3428, 1672, 1626, 1366, 1253, 1131, 1069, 1047, 998, 902. H-NMR: cis isomer 10a: 6.93 (dd, J=15.8,
10.3, HꢀC(7)); 6.08 (d, J=15.8, HꢀC(8)); 5.17 (br. s, 1 HꢀC=C(5)); 4.69 (br. s, 1 HꢀC=C(5));
4.10–4.02 (m, HꢀC(4)); 2.56 (d, J=10.3, HꢀC(6)); 2.28 (s, Me(10)); 2.01–1.92 (m, 1 H), 1.64–1.50
(m, 2 H), 1.49–1.39 (m, 1 H) (CH2(2), CH2(3)); 0.89 (s, 1 MeꢀC(1)); 0.88 (s, 1 MeꢀC(1)); trans-isomer
10b: 6.89 (dd, J=15.8, 9.9, HꢀC(7)); 6.14 (dd, J=15.8, 0.6, HꢀC(8)); 5.08–5.06 (m, 1 HꢀC=C(5)); 4.72
(br. s, 1 HꢀC=C(5)); 4.32–4.26 (m, HꢀC(4)); 2.98 (d, J=9.9, HꢀC(6)); 2.26 (s, Me(10)); 1.91–1.81 (m, 1
H), 1.74–1.57 (m, 2 H), 1.49–1.39 (m, 1 H) (CH2(2), CH2(3)); 0.94 (s, 1 MeꢀC(1)); 0.88 (s, 1 MeꢀC(1)).
MS: 208 (3, M+), 193 (8), 190 (4), 175 (12), 165 (100), 157 (3), 150 (39), 147 (78), 135 (29), 122 (43), 109
(40), 107 (69), 105 (43), 95 (58), 91 (59), 81 (39), 79 (41), 69 (41), 67 (32), 55 (36). Anal. calc. for C13H20O2:
C 74.96, H 9.68; found: C 75.10, H 9.65.
cis-4-[(4-Nitrobenzoyl)oxy]-g-ionone (=(3E)-4-{cis-5-[4-Nitrobenzoyl)oxy]-2,2-dimethyl-6-methyl-
enecyclohexyl)but-3-en-2-one; 12a). A sample of 10a/10b (7 g, 33.6 mmol) in CH2Cl2 (30 ml) was treated
with 4-nitrobenzoyl chloride (7.6 g, 41 mmol) and pyridine (20 ml). After workup, the crude product was
purified by CC (hexane/AcOEt 8 :2): 12a (11 g, 92%). Two crystallizations from MeOH afforded crystal-
line 12a (4.9 g, yield of recrystallizations 41%; up to 98% pure by NMR). M.p. 101–1028. IR: 1724, 1671,
1605, 1526, 1357, 1278, 1104, 990, 904, 722. 1H-NMR: 8.34–8.24 (m, 4 arom. H); 6.97 (dd, J=15.6, 10.1,
HꢀC(7)); 6.16 (d, J=15.6, HꢀC(8)); 5.54–5.46 (m, HꢀC(4)); 5.12 (s, 1 HꢀC=C(5)); 4.81 (s, 1 HꢀC=
C(5)); 2.72 (d, J=10.1, HꢀC(6)); 2.23 (s, Me(10)); 2.12–2.01 (m, 1 H), 1.94–1.82 (m, 1 H), 1.79–1.69
(m, 1 H), 1.60–1.49 (m, 1 H) (CH2(2), CH2(3)); 0.96 (s, 2 MeꢀC(1)). 13C-NMR: 197.4; 163.5; 150.6;